CoJourney Inc.

Philadelphia, PA (US operations); Hangzhou, China (primary manufacturing)
AAV Adenoviral Lentiviral Retroviral Plasmid DNA mRNA sgRNA Exosome Custom Viral Vectors
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (2) ○ EMA GMP ○ MHRA GMP

Quick Facts: CoJourney Inc.

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Philadelphia, PA (US operations); Hangzhou, China (primary manufacturing)
Modalities
AAV, Adenoviral, Lentiviral, Retroviral, Plasmid DNA, mRNA, sgRNA, Exosome, Custom Viral Vectors
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Adenoviral, Lentiviral, Retroviral, Plasmid DNA, mRNA, sgRNA, Exosome, Custom Viral Vectors
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press2 articles
Broad modality coverage (9 modalities)

Recent News 2 articles

news Wed, 18 Ja
Exegenesis Bio Announces FDA Clearance of Investigational New Drug (IND) Application for EXG102-031; A Novel Gene Therapy for the Treatment of neovascular Age-Related Macular Degeneration (nAMD) - Business Wire
Source →
news Wed, 12 Ju
CoJourney raises $30M to expand operations in Montgomery County - The Business Journals
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Adenoviral CDMOs → Lentiviral CDMOs → Retroviral CDMOs → Plasmid DNA CDMOs → mRNA CDMOs → sgRNA CDMOs → Exosome CDMOs → Custom Viral Vectors CDMOs →

Similar CDMOs

Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.2
AAV, Lentiviral, Plasmid DNA, Adenoviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Catalent
Somerset, NJ (Now Novo Holdings)
Signal Score: 81.0
AAV, CAR-T, Lentiviral, Plasmid DNA
Lonza
Basel, Switzerland
Signal Score: 79.2
AAV, Lentiviral, Cell Therapy, mRNA
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral